BridgeMD
New treatment option for Acquired Brain Injury
Official title Implementation of a HABIT-ILE Intervention at William Lennox Neurological Hospital (NeuREHA)
ClinicalTrials.gov ID: NCT05900778
What this study is testing
- What it's testing
- Using a randomized controlled trial design, in an hospital environment, possible changes induced by the "Hand-arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE)" treatment program will be investigated in functional activities of daily living, motor and cognitive assessment of children with acquired brain injury.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 to 18
You may be able to join if
- children with acquired brain injury of school
- age 5 to 18 years inclusive
You likely can't join if
- Unstable seizure
- programmed botulinum toxin or orthopedic surgery in the 6 months previous to the intervention, during intervention period or 3months after the...
- Severe visual or cognitive impairments likely to interfere with intervention or testing session completion
The study team makes the final eligibility decision.
Where it's taking place
- Ottignies-Louvain-la-Neuve, Brabant-Wallon, Belgium
- Brussels, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ottignies-Louvain-la-Neuve, Brabant-Wallon, Belgium; Brussels, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.